Français
English
Le centre
About us
Coordination and the Medical Team
Surgical teams
Microbiology Team
CRIOAc Lyon in the news
Missions
Statistics
Localisation
Espace patient
Qu’est-ce qu’une infection ostéoarticulaire ?
The care pathway
Your first CRIOAc appointment
Surgical therapy
Microbiological diagnostics
Medical therapy
Convalescent care homes
Innovative therapies
Phagothérapie
Bone substitutes
Antibiotic-loaded bone cements
Examples of satisfactory functional outcomes
Where our patients come from
Practical information
Rendez-vous de consultation
Localisation
Questionnaire de satisfaction
Espace pro
Multidisciplinary team meetings at CRIOAc Lyon
Critères de complexité
Calendrier
Bilan
Réseau des CRIOAc
Comité scientifique des CRIOAc
Rapport annuel DGOS
Algorithm for the diagnosis of prosthetic joint infection
Recommandations
Where our patients come from
Innovative therapies
Phagothérapie
Bone substitutes
Antibiotic-loaded bone cements
Examples of management of complex cases
Cas cliniques publiés
Recherche
The research teams working with CRIOAc
Physiopathologie de l’infection de prothèse
Innovative therapies
Phagothérapie
Lysines de bactériophage
Bone substitutes
Antibiotic-loaded bone cements
Lyon BJI Study group
Publications
Communications orales
Cas cliniques
Posters
Thèses
CONVICTION Trial
PhagoDAIR I trial
CF-301-108 trial
Enseignement
L’enseignement et le CRIOAc Lyon
Recommandations
Communications orales
Diplôme Inter-Universitaire
DES et DESC de Maladies Infectieuses
Formation continue et webinaires
Congrès National des CRIOAc
Ouvrages
boibieux
2022
Publications
Necrotizing external otitis: analysis of relapse risk factors in 66 patients managed during a 12 year period
Necrotizing external otitis: analysis of relapse risk factors in 66 patients managed during a 12 year period
2018
Publications
Non-compliance with IDSA guidelines for patients presenting with methicillin-susceptible Staphylococcus aureus prosthetic joint infection is a risk factor for treatment failure
2016
Publications
Pristinamycin in the treatment of MSSA bone and joint infection
Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration